The global healthcare industry is witnessing increasing demand for advanced antibiotics due to the rising prevalence of bacterial infections and antimicrobial resistance. Dalbavancin, a long-acting lipoglycopeptide antibiotic, has gained significant attention for its effectiveness in treating acute bacterial skin and skin structure infections caused by gram-positive bacteria. The growing focus...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek